Portuguese defender invests more than €1 million in personalized supplements company already backed by Cristiano Ronaldo. Manchester United and Portugal … Continue reading "Diogo Dalot joins CR7 and invests in...
Company gears up for pivotal trials of AI-developed IPF drug candidate following encouraging Phase 2 data. AI-driven drug discovery powerhouse … Continue reading "Insilico seals unicorn status after landing $110m...
Immorta Bio is developing autologous stem cell and immunotherapy solutions to combat aging and enhance cellular regeneration. Aging is the … Continue reading "Harnessing the power of personalized cell therapy"...
London is the setting for the next edition of a premier global gathering for leaders in longevity research and technology … Continue reading "Founders Longevity Forum London reveals first wave...
Progress in spinal cord injury lays the foundation for regenerative therapies that ‘target aging and chronic disease at a cellular … Continue reading "Cellino’s regenerative medicine tie-up with Matricelf is...
New COO Michael Ringel says company is confident as it prepares for clinical studies in glaucoma and NAION later this … Continue reading "Life Bio ready for world’s first partial...
New research highlights the dominant role of environmental exposures in health outcomes, disease risk and longevity. The relative influence of … Continue reading "Exposome has tenfold impact on mortality risk...
Regenerative medicine startup aims to regenerate damaged tissues, modulate chronic inflammation and extend functional healthspan. Longevity biotech ReParris has launched … Continue reading "ReParris emerges to redefine aging as a...
Research also identifies key methylation sites, along with processes and transcription factor targets linking epigenetics to health and aging. A … Continue reading "New study shows CheekAge clock is ‘significantly...
Biotech gains DSMB approval to escalate dosing as it advances novel organ regeneration therapy for end-stage liver disease. LyGenesis, a … Continue reading "LyGenesis progresses Phase 2a clinical trial in...
